Completed PHASE4 INTERVENTIONAL 2-arm NCT00605098

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy in HIV-infected Women

Sponsor: Ministry of Health, Brazil

Conditions HIV Infections Pregnancy

Interventions Lopinavir / ritonavir Lopinavir/ritonavir

Updated 5 times since 2017 Last updated: Oct 25, 2013 Started: Feb 29, 2008 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on HIV Infections and Pregnancy, this trial is completed. The trial is conducted by Ministry of Health, Brazil and has accumulated 5 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, Brazil
Oswaldo Cruz Foundation

Data source: Oswaldo Cruz Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nova Iguaçu, Brazil
• Rio de Janeiro, Brazil